Literature DB >> 16541113

Vascular risk factors and erectile dysfunction in a cohort of healthy men.

A Ponholzer1, C Temml, M Rauchenwald, S Madersbacher.   

Abstract

To determine the impact of vascular risk factors in the genesis of erectile dysfunction (ED) in a cohort of healthy men. Participants of a health-screening project were carefully selected as men without known vascular disease. Erectile dysfunction was quantified via the IIEF5-questionnaire. All men underwent a detailed health examination including determination of blood pressure, blood lipid profile and fasting serum glucose. In total 1519 men (42.9+/-7.9 years) were analysed. Age (P < 0.01), elevated levels of total cholesterol (P = 0.04) and low-density lipoproteins (LDL) (P = 0.02) were associated with moderately to severely impaired erectile function (IIEF5: <12). Men with total cholesterol >240 mg/dl had a 2.7 (1.5-4.9)-fold increased risk for moderate to severe ED, the respective figure for LDL >160 mg/dl was 2.6 (1.4-4.9). In this well characterized, healthy population, elevated serum lipids are the most important risk factors for the development of ED.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16541113     DOI: 10.1038/sj.ijir.3901468

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  9 in total

Review 1.  Mean platelet volume as a predictive marker of erectile dysfunction: a meta-analysis.

Authors:  Nur Rasyid; Maruto Harjanggi; Widi Atmoko; Ponco Birowo
Journal:  Int J Impot Res       Date:  2022-01-29       Impact factor: 2.896

2.  Potential Linkage between High Normalized Electromechanical Activation Time (EMAT), an Early Systolic Time Interval Abnormality with Metabolic Syndrome.

Authors:  Kai-Hung Cheng; Jiun-Hung Geng; Cheng-Hsueh Lee; Chia-Chu Liu; Chao-Ping Wang; Shu-Pin Huang
Journal:  Acta Cardiol Sin       Date:  2021-11       Impact factor: 2.672

Review 3.  Erectile dysfunction and diabetes: A melting pot of circumstances and treatments.

Authors:  Giuseppe Defeudis; Rossella Mazzilli; Marta Tenuta; Giovanni Rossini; Virginia Zamponi; Soraya Olana; Antongiulio Faggiano; Paolo Pozzilli; Andrea M Isidori; Daniele Gianfrilli
Journal:  Diabetes Metab Res Rev       Date:  2021-09-21       Impact factor: 8.128

Review 4.  Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions.

Authors:  Ajay Nehra
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

5.  Elevated plasma aldosterone is an independent risk factor for erectile dysfunction in men.

Authors:  Fei Wu; Shanhua Mao; Tianfang Yu; Haowen Jiang; Qiang Ding; Gang Xu
Journal:  World J Urol       Date:  2015-11-02       Impact factor: 4.226

6.  The Associations of Novel Vitamin D3 Metabolic Gene CYP27A1 Polymorphism, Adiponectin/Leptin Ratio, and Metabolic Syndrome in Middle-Aged Taiwanese Males.

Authors:  Kai-Hung Cheng; Edward Hsi; Chia-Chu Liu; Chun-Nung Huang; Yung-Chin Lee; Chih-Sheng Chu; Bo-Ying Bao; Chu-Fen Chang; Shu-Pin Huang; Po-Lin Kuo; Wen-Ter Lai
Journal:  Int J Endocrinol       Date:  2015-01-05       Impact factor: 3.257

7.  Relationship between the risk factors of cardiovascular disease by testing biochemical markers and young men with erectile dysfunction: a case-control study.

Authors:  Wen-Jing Ma; Mao Qin; Tian-Wei Cui; Xiu-Ping Zhang; Zheng-Hao Ke; Zhen-Kun Pan; Yun-Xiao Gao; Bao-Xing Liu
Journal:  Transl Androl Urol       Date:  2021-02

8.  History, mystery and chemistry of eroticism: Emphasis on sexual health and dysfunction.

Authors:  M R Asha; G Hithamani; R Rashmi; K H Basavaraj; K S Jagannath Rao; T S Sathyanarayana Rao
Journal:  Indian J Psychiatry       Date:  2009-04       Impact factor: 1.759

9.  The impact of estradiol and 1,25(OH)2D3 on metabolic syndrome in middle-aged Taiwanese males.

Authors:  Kai-Hung Cheng; Shu-Pin Huang; Chun-Nung Huang; Yung-Chin Lee; Chih-Sheng Chu; Chu-Fen Chang; Wen-Ter Lai; Chia-Chu Liu
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.